No paralogue variants have been mapped to residue 91 for KCNJ2.
| KCNJ2 | EKGQ--RYLADIFTTCVDIRWRWMLVIFCL>A<FVLSWLFFGCVFWLIALLHGDLDAS----- | 116 |
| KCNJ1 | A-QSRFIFFVDIWTTVLDLKWRYKMTIFIT>A<FLGSWFFFGLLWYAVAYIHKDLPEF--HP- | 114 |
| KCNJ3 | SETS--RYLSDLFTTLVDLKWRWNLFIFIL>T<YTVAWLFMASMWWVIAYTRGDLNKA--HV- | 117 |
| KCNJ4 | NKSQ--RYMADIFTTCVDTRWRYMLMIFSA>A<FLVSWLFFGLLFWCIAFFHGDLEAS--PGV | 93 |
| KCNJ5 | -ETY--RYLSDLFTTLVDLKWRFNLLVFTM>V<YTVTWLFFGFIWWLIAYIRGDLDHV--GD- | 123 |
| KCNJ6 | -ETY--RYLTDIFTTLVDLKWRFNLLIFVM>V<YTVTWLFFGMIWWLIAYIRGDMDHI--ED- | 126 |
| KCNJ8 | -EQG--RFLQDIFTTLVDLKWRHTLVIFTM>S<FLCSWLLFAIMWWLVAFAHGDIYAY--MEK | 107 |
| KCNJ9 | -ETY--RYLTDLFTTLVDLQWRLSLLFFVL>A<YALTWLFFGAIWWLIAYGRGDLEHL--ED- | 94 |
| KCNJ10 | DKRF--LYLKDLWTTFIDMQWRYKLLLFSA>T<FAGTWFLFGVVWYLVAVAHGDLLEL--DP- | 101 |
| KCNJ11 | -EQG--RFLQDVFTTLVDLKWPHTLLIFTM>S<FLCSWLLFAMAWWLIAFAHGDLAP----S- | 103 |
| KCNJ12 | EKSQ--RYLADMFTTCVDIRWRYMLLIFSL>A<FLASWLLFGIIFWVIAVAHGDLEPA--EG- | 117 |
| KCNJ13 | R-GL--AYLRDAWGILMDMRWRWMMLVFSA>S<FVVHWLVFAVLWYVLAEMNGDLELDHDAP- | 92 |
| KCNJ14 | GQGA--RYLSDLFTTCVDVRWRWMCLLFSC>S<FLASWLLFGLAFWLIASLHGDLAAP--P-- | 122 |
| KCNJ15 | GIYL--LYLQDLWTTVIDMKWRYKLTLFAA>T<FVMTWFLFGVIYYAIAFIHGDLEPG--EP- | 100 |
| KCNJ16 | GEWG--SYVVDIFTTLVDTKWRHMFVIFSL>S<YILSWLIFGSVFWLIAFHHGDLLND--P-- | 106 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.A91V | c.272C>T | Putative Benign | SIFT: tolerated Polyphen: benign |